Perth-based biotechnology company Xceed Capital Ltd will net over $6 million in scrip from selling its majority shareholding in PolyNovo Biomaterials Ltd to a Melbourne company.
18 Jul 2008
Subscribe today for award-winning, unbiased and trusted journalism